Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/11329
Full metadata record
DC FieldValueLanguage
dc.contributor.authorGrossmann, Mathisen
dc.contributor.authorZajac, Jeffrey Den
dc.date.accessioned2015-05-16T00:55:08Z
dc.date.available2015-05-16T00:55:08Z
dc.date.issued2011-09-01en
dc.identifier.citationEndocrinology and Metabolism Clinics of North America; 40(3): 655-71, xen
dc.identifier.govdoc21889727en
dc.identifier.otherPUBMEDen
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/11329en
dc.description.abstractAndrogen deprivation therapy (ADT) is a major component of the contemporary management of prostate cancer. ADT's use is increasing rapidly. The side effects of this therapy include loss of bone mass and fractures, increase in fat mass, and worsening of insulin resistance, the metabolic syndrome, diabetes and cardiovascular risk, and anemia and loss of muscle. Neuropsychological and sexual symptoms are common. The impact of these side effects is often overlooked or underestimated in decisions about prostate cancer therapy. This review surveys the data relating to the side effects of ADT and provides recommendations regarding their minimization and management.en
dc.language.isoenen
dc.subject.otherAndrogen Antagonists.adverse effects.therapeutic useen
dc.subject.otherAnimalsen
dc.subject.otherAntineoplastic Agents, Hormonal.adverse effects.therapeutic useen
dc.subject.otherCarcinoma.drug therapy.epidemiology.metabolism.physiopathologyen
dc.subject.otherCardiovascular Physiological Phenomena.drug effectsen
dc.subject.otherDietary Supplements.utilizationen
dc.subject.otherDrug-Related Side Effects and Adverse Reactions.epidemiology.therapyen
dc.subject.otherHumansen
dc.subject.otherLife Styleen
dc.subject.otherMaleen
dc.subject.otherProstatic Neoplasms.drug therapy.epidemiology.metabolism.physiopathologyen
dc.titleManagement of side effects of androgen deprivation therapy.en
dc.typeJournal Articleen
dc.identifier.journaltitleEndocrinology and metabolism clinics of North Americaen
dc.identifier.affiliationDepartment of Medicine Austin Health/Northern Health, University of Melbourne, Heidelberg, Victoria 3084, Australiaen
dc.identifier.doi10.1016/j.ecl.2011.05.004en
dc.description.pages655-71, xen
dc.relation.urlhttps://pubmed.ncbi.nlm.nih.gov/21889727en
dc.type.austinJournal Articleen
local.name.researcherGrossmann, Mathis
item.languageiso639-1en-
item.openairetypeJournal Article-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.fulltextNo Fulltext-
item.grantfulltextnone-
item.cerifentitytypePublications-
crisitem.author.deptEndocrinology-
crisitem.author.deptEndocrinology-
crisitem.author.deptMedicine (University of Melbourne)-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

32
checked on Nov 6, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.